Thank you for submitting your manuscript to the EMBO Journal. Please find enclosed the comments of two of the three reviewers whom we had asked to review your manuscript for EMBO Journal. We are still waiting for a third report, but given the two present reports I can take a decision now. As you can see below, both referees appreciate the analysis and find the described link between Lamin A function and telomere biology very interesting. While referee #1 has only a minor concern, referee #3 raises a number of different issues that have to be resolved in order for further consideration here. In particular, some of the raised issues concern 53BP1 and some further insight into how loss of LaminA leads to decreased 53BP1 levels and if this is directly linked to the telomere phenotypes observed upon loss of LaminA is needed. Should you be able to address the criticisms of the reviewers in full, we would consider a revised manuscript. Acceptance of your paper will be dependent upon persuading the referees that you have provided a sufficient amount of new data to answer all their criticisms. I should also add that it is EMBO Journal policy to allow a single round of revision only and it is therefore important to address the points raised at this stage. I will forward you the comments of the third referee as soon as we receive them.
Thank you for submitting your manuscript to the EMBO Journal. Please find enclosed the comments of two of the three reviewers whom we had asked to review your manuscript for EMBO Journal. We are still waiting for a third report, but given the two present reports I can take a decision now. As you can see below, both referees appreciate the analysis and find the described link between Lamin A function and telomere biology very interesting. While referee #1 has only a minor concern, referee #3 raises a number of different issues that have to be resolved in order for further consideration here. In particular, some of the raised issues concern 53BP1 and some further insight into how loss of LaminA leads to decreased 53BP1 levels and if this is directly linked to the telomere phenotypes observed upon loss of LaminA is needed. Should you be able to address the criticisms of the reviewers in full, we would consider a revised manuscript. Acceptance of your paper will be dependent upon persuading the referees that you have provided a sufficient amount of new data to answer all their criticisms. I should also add that it is EMBO Journal policy to allow a single round of revision only and it is therefore important to address the points raised at this stage. I will forward you the comments of the third referee as soon as we receive them.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal REFEREE REPORTS Referee #1 (Remarks to the Author):
This is well-written manuscript that makes an important connection in the study of nuclear organization. The authors report connections between A-type lamin function and telomere biology. They find that cells lacking A-type lamins have altered distribution of mouse telomeres and altered heterochromatic marks at telomeres. Some of these findings can be linked to reduced levels of retinoblastoma protein family members, a known consequence of loss of A-type lamins. Others are independent of Rb family members. These findings are important since mutations in A-type lamins are linked to Hutchinson-Gilford progeria and altered telomere function is a possible link to disease mechanism. Also, loss of A-type lamin expression is linked to tumor progression and altered telomere function may be related to this phenotype as well. Of particular interest is the finding that 53BP1 levels are reduced in cells lacking A-type lamins. This could provide an explanation for altered DNA damage responses associated with laminopathies. The data presented in this study is generally very sound. These findings will be of considerable interest to a wide readership and will foster further studies. There is one nominal concern (mostly editorial) that, if addressed, would further clarify the manuscript. Differences in the TRF analysis of adult fibroblasts (vs. MEFs) are stated to indicate that telomere defects are exacerbated during aging. This at least in the formal since is an overstatement. The authors should be clear what they mean by the term "aging," since these two populations of fibroblasts may be different for a range of reasons other than normal aging. In addition, telomere length appears to be longer in adult fibroblasts than MEFs, although cross-comparison may be difficult. Is there a reason for this?
Referee #3 (Remarks to the Author):
In this manuscript, the authors investigate the role of A-type lamins on telomere biology and demonstrate that loss of A-type lamins results in altered distribution of telomeres in the nucleus, telomere shortening, reduced tri-methylation of H4K20 at telomeres, and increased genome instability associated with an increase in chromosome number and breaks. Furthermore, uncapping of telomeres in the absence of A-type lamins results in a reduction of telomere fusions (compared to Lmna+/+ cells), which the authors correlate with decreased protein levels of 53BP1. Overall, the manuscript is well written and the work is clearly presented. Furthermore, the data provide evidence for a number of interesting findings linking telomere biology to nuclear organization, and specifically the nuclear lamina. However, the data raise a number of questions and lack several key experiments as outlined below. In light of these issues, I feel that some further work would be needed before I could consider this work suitable for publication in EMBO J.
1) The authors reference several publications demonstrating that cell cycle phase and senescence result in altered telomere positioning within the nucleus. As lamins are known to affect DNA transactions including replication, it is important to show cell cycle profiles (FACS analysis) of Lmna+/+ and Lmna-/-cells to determine whether or not cell cycle differences might contribute to the results presented in Fig 1. Along these same lines, since lamins are important for the stability of Rb, could differences in telomere distribution be related to differences in the percentage of senescent cells between Lmna-/-and Lmna+/+ cells? Experiments examining -gal staining (for example) would address this question.
2) In Fig. 1B and C, the authors find that loss of A-type lamins result in a shift in the localization of telomeres towards the nuclear periphery. In addition, using ChIP experiments they demonstrate that lamins A and C associate with telomeric DNA suggesting that lamins tether telomeres to the nuclear matrix. Wouldn't one expect that if lamins are important for tethering telomeres, that their loss would result in the movement of telomeres to the interior of the nucleus (away from the periphery)?
3) A decrease in tri-methylation of H4K20 is demonstrated in Lmna-/-cells compared to wild-type (Fig. 3) . Is this decrease due to reduced expression of SUV4-20H1 or SUV4-20H2? In addition, cells deficient for SUV4-20H showed reduced levels of H4K20me3 at telomeres, and these changes were accompanied by telomere elongation (Benetti et al., J Cell Biol 178:925-936, 2007) . A mechanism (or at least a discussion) needs to be provided as to why reduced H4K20me3 correlates with longer telomeres as described by Benetti et al., and shorter telomeres described in this report.
4) It is not clear why the authors use immunoprecipitation followed by Western blotting to demonstrate loss or reduction of Rb, p130, and p107 in Lmna-/-cells compared to Lmna+/+ cells. Such experiments don't allow for loading controls. It would be better just to prepare lysates (ex. in Laemmli buffer) and then probe for the levels of these proteins by Western blotting. These same lysates could be used to examine levels of SUV4-20H1 or SUV4-20H2, as mentioned above. 5) Increased genome instability is demonstrated for Lmna-/-cells in Fig. 4 and Suppl Fig. 4 . Several of these phenotypes, as well as the reduced H4K20me3 levels, are similar to cells lacking Rb family members. It would be interesting to complement and/or overexpress Rb (and/or other family members p107 and p130) in Lmna-/-cells to determine whether or not the genome instability, telomere shortening, and altered nuclear positioning can be corrected by Rb expression. While such work might be outside the scope of the current manuscript, the authors should at least discuss this type of possibility. 6) In the text (page 13), the authors state that no chromosome end-to-end fusions were found in Lmna-/-MEFs, while the number of fusions presented in Suppl Fig 4C reflect that 4 fusions were identified. Therefore, the text should be modified accordingly. Albeit a low number, there is a twofold increase in fusions (1.5 compared to 0.8) in Lmna-/-compared to Lmna+/+ cells. Is this significant? In addition, for comparison purposes, the results presented in Supplemental Fig. 4C regarding telomere fusions should be combined and presented in Fig. 5. 7) It would be nice if the authors could address whether or not there is a difference between Lmna-/-and Lmna+/+ cells in telomeric recombination as measured for example by telomeric sisterchromatid exchange (as performed previously by the authors in Gonzalo et al., Nat Cell Biol 8:416-424, 2006) . In light of the increased genome instability (increased signal free ends, increased chromosome breaks, etc), such experiments would explain if or how cells lacking A-type lamins deal with these breaks. Furthermore it would be interesting for the authors to determine if the decrease in telomere fusions seen in Lmna-/-+ TRF2 B M correlates with an increase in telomere recombination. 8) Although the authors demonstrate that Lmna+/+ and Lmna-/-cells were indeed transfected with a dnTRF2 (Fig 5B) , they do not provide evidence for telomere uncapping and activation of a DNA damage response. Immunofluorescence experiments should be performed with antibodies against TRF1 and H2AX as well as TRF1 and 53BP1 (see below) to ensure that the dnTRF2 in Lmna-/-cells does indeed result in telomere uncapping. In addition, as TRF2 and POT1 have been shown to prevent end-to-end fusions, are there any differences in the expression of TRF2 and POT1 in Lmna-/-compared to Lmna+/+ cells? 9) In Fig 6 , the authors demonstrate reduced 53BP1 expression in cells deficient or down-regulated for A-type lamins. In Fig 6A, the expression levels of 53BP1 are reduced in Lmna-/-cells while in Fig. 6B no 53BP1 protein is detected in these same cells. The authors should explain this discrepancy or show more than one film exposure. Additionally, the authors should perform immunofluorescence experiments (described above in point 8) as an alternative approach to look at 53BP1 expression and localization. Furthermore the authors should address whether the reduced protein levels of 53BP1 in the absence of A-type lamins is related to protein degradation by performing experiments in the absence and presence of proteasome inhibitors, or additional experiments to address how 53BP1 is destabilized. Finally, in Fig 6A , the authors fail to examine protein levels of several key NHEJ and DDR factors including XRCC4, DNA Ligase IV, DNA PKcs, XLF, and MDC1. Such results are necessary to make a point regarding the specificity of 53BP1 reduction. 10) Most importantly, the data presented in Figs. 5 and 6 merely show a correlation between 53BP1 expression and decreased telomere fusions in Lmna-/-+ TRF2 B M cells. The authors need to provide a direct mechanistic link, for example, by repeating these experiments -/+ complementation with 53BP1 as has been described previously (Dimitrova et al., Nature 456:524-528, 2008 Fig. 2B. b) As the Tudor domain of 53BP1 has been reported to bind di-methylated H3K79 or H4K20, it would be interesting to examine these marks by ChIP using telomeric and pericentric probes as described in Fig 3. 
Additional Correspondence from Authors to Editor 31 March 2009
Thanks for considering our manuscript for publication in EMBO Journal. We are very happy about the referees finding our observations of importance to understand molecular mechanisms altered upon loss of A-type lamins function which can be related to the pathophysiology of disease. We appreciate the suggestions offered by referee #3 to continue characterizing how A-type lamins participate in the regulation of telomere biology and the regulation of 53BP1 stability. We are planning to answer experimentally the questions raised by this referee. We are however, worried about the time that all the additional experiments might take us. In addition, we would like to know whether we need to take into consideration the comments of referee #2, once his/her comments are received.
Additional Correspondence from Editor to Authors 01 April 2009
Thank you for your email. I am sorry for the slight delay in getting back to you. First of all, I have not heard anything from referee #2 and at this stage we will just move ahead with the two reports that we have. So in other words there will be no third report. Regarding the concerns raised by referee #3. I find the comments provided by this referee very helpful and it will be important to address those concerns. I also recognize that it will be a lot of work to carry out the additional experiments, but what I can offer is that I can easily grant an extension up to 6 months if that would be helpful. Answers to Reviewer #2:
This is well-written manuscript that makes an important connection in the study of nuclear organization. The authors report connections between A-type lamin function and telomere biology. They find that cells lacking A-type lamins have altered distribution of mouse telomeres and altered heterochromatic marks at telomeres. Some of these findings can be linked to reduced levels of retinoblastoma protein family members, a known consequence of loss of A-type lamins. Others are independent of Rb family members. These findings are important since mutations in A-type lamins are linked to Hutchinson-Gilford progeria and altered telomere function is a possible link to disease mechanism. Also, loss of A-type lamin expression is linked to tumor progression and altered telomere function may be related to this phenotype as well. Of particular interest is the finding that 53BP1 levels are reduced in cells lacking A-type lamins. This could provide an explanation for altered DNA damage responses associated with laminopathies.
The data presented in this study is generally very sound. These findings will be of considerable interest to a wide readership and will foster further studies. There is one nominal concern (mostly editorial) that, if addressed, would further clarify the manuscript. Answers to Reviewer #3:
We appreciate the comments of the reviewer about the clarity of the manuscript, and the interesting nature of our findings linking telomere biology to nuclear organization. We have addressed experimentally the concerns raised by the reviewer.
1) The authors reference several publications demonstrating that cell cycle phase and senescence result in altered telomere positioning within the nucleus. As lamins are known to affect DNA transactions including replication, it is important to show cell cycle profiles (FACS analysis) of Lmna+/+ and Lmna-/-cells to determine whether or not cell cycle differences might contribute to the results presented in Fig 1. Along these same lines, since lamins are important for the stability of Rb, could differences in telomere distribution be related to differences in the percentage of senescent cells between Lmna-/-and Lmna+/+ cells? Experiments examining -gal staining (for example) would address this question. 
In summary, the changes in nuclear distribution of telomeres upon loss of A-type lamins are not due to differences in cell cycle profiles or number of senescent cells between the two genotypes.
We completely agree with the reviewer that the opposite result was originally expected. Thus, we were very surprised by our findings that loss of A-type lamins leads to a shift in the distribution of telomeres towards the nuclear periphery. However, after performing the nuclear distribution studies many times, we are very confident that this is the case. We would like to direct the reviewer to the following paragraph in the discussion where this issue is addressed. "The change in localization of telomeres away from the nuclear center and towards the periphery upon loss of A-type lamins is intriguing. A-type lamins are highly enriched at the nuclear periphery, and are also found throughout the nucleoplasm (Schermelleh, Carlton et al. 2008). We reasoned that loss of A-type lamins could lead to detachment of telomeres from the nuclear periphery. Conversely, we found that the localization of telomeres shifts towards the nuclear periphery in the absence of A-type lamins, raising the possibility that the nuclear periphery represents a default pathway for telomere localization. In this model, A-type lamins would play an active role in the localization of telomeres throughout the entire nucleoplasm in mouse cells. A recent study showing that alterations of the nuclear lamina during senescence are associated with increased aggregation of telomeres at the nuclear periphery supports this model (Raz et al., 2008)".
3) A decrease in tri-methylation of H4K20 is demonstrated in Lmna-/-cells compared to wild-type (Fig. 3) . Is this decrease due to reduced expression of SUV4-20H1 or SUV4-20H2? In addition, cells deficient for SUV4-20H showed reduced levels of H4K20me3 at telomeres, and these changes were accompanied by telomere elongation (Benetti et al., J Cell Biol 178:925-936, 2007) . A mechanism (or at least a discussion) needs to be provided as to why reduced H4K20me3 correlates with longer telomeres as described by Benetti et al., and shorter telomeres described in this report. Gonzalo et al.(Gonzalo, Garcia-Cao et al. 2005; Benetti, Gonzalo et al. 2007) Fig. 4 and Suppl Fig. 4 . Several of these phenotypes, as well as the reduced H4K20me3 levels, are similar to cells lacking Rb family members. It would be interesting to complement and/or overexpress Rb (and/or other family members p107 and p130) in Lmna-/-cells to determine whether or not the genome instability, telomere shortening, and altered nuclear positioning can be corrected by Rb expression. While such work might be outside the scope of the current manuscript, the authors should at least discuss this type of possibility. 6) In the text (page 13), the authors state that no chromosome end-to-end fusions were found in Lmna-/-MEFs, while the number of fusions presented in Suppl Fig 4C reflect that 4 fusions were identified. Therefore, the text should be modified accordingly. Albeit a low number, there is a twofold increase in fusions (1.5 compared to 0.8) in Lmna-/-compared to Lmna+/+ cells. Is this significant? In addition, for comparison purposes, the results presented in Supplemental Fig. 4C regarding telomere fusions should be combined and presented in Fig. 5 . (Fig 5B) , they do not provide evidence for telomere uncapping and activation of a DNA damage response. Immunofluorescence experiments should be performed with antibodies against TRF1 and H2AX as well as TRF1 and 53BP1 (see below) to ensure that the dnTRF2 in Lmna-/-cells does indeed result in telomere uncapping. In addition, as TRF2 and POT1 have been shown to prevent end-to-end fusions, are there any differences in the expression of TRF2 and POT1 in Lmna-/-compared to Lmna+/+ cells?
The study by Benetti et al. mentioned by the reviewer as well as the study by

5) Increased genome instability is demonstrated for Lmna-/-cells in
As suggested by the reviewers we have performed Immuno-FISH to determine if expression of TRF2 B M induces telomere uncapping and activation of the DNA damage response pathway in Lmna+/+ and Lmna-/-MEFs (new figure 5B). Our results show that the expression of TRF2 B M leads to the formation of TIFs both in Lmna+/+ and Lmna-/-MEFs.
In addition, we have performed western blots with TRF1, TRF2, and POT1 antibodies (new figure 6D) . No differences in the levels of these proteins were observed between Lmna+/+ and Lmna-/-MEFs, indicating that alternative mechanisms are responsible for the deficiency in NHEJ of dysfunctional telomeres. Fig 6 , the authors demonstrate reduced 53BP1 expression in cells deficient or down-regulated for A-type lamins. In Fig 6A , the expression levels of 53BP1 are reduced in Lmna-/-cells while in Fig. 6B no 53BP1 protein is detected in these same cells. The authors should explain this discrepancy or show more than one film exposure. Additionally, the authors should perform immunofluorescence experiments (described above in point 8) as an alternative approach to look at 53BP1 expression and localization. Furthermore the authors should address whether the reduced protein levels of 53BP1 in the absence of A-type lamins is related to protein degradation by performing experiments in the absence and presence of proteasome inhibitors, or additional experiments to address how 53BP1 is destabilized. Finally, in Fig 6A, the authors fail to examine protein levels of several key NHEJ and DDR factors including XRCC4, DNA Ligase IV, DNA PKcs, XLF, and MDC1. Such results are necessary to make a point regarding the specificity of 53BP1 reduction.
9) In
We have modified figure 6 to clarify the discrepancy of the previous figure, which Fig. 2B .
We thank the reviewer for point out to us this mistake.
b) As the Tudor domain of 53BP1 has been reported to bind di-methylated H3K79 or H4K20, it would be interesting to examine these marks by ChIP using telomeric and pericentric probes as described in Fig 3. As Thank you for submitting your revised manuscript to the EMBO Journal. I asked the original referee #3 to review the revised manuscript and I have now received the comments. As you can see below, this referee finds that you have satisfactorily addressed the original issues raised and supports publication here. However, the referee also has a few remaining issues that need to be resolved before formal acceptance here. I would therefore like to ask you to respond to the remaining points raised by referee #3 in a final round of revision. When you send us your revision, please include a cover letter with an itemised list of all changes made, or your rebuttal, in response to comments from review.
Yours sincerely,
